Dr. Francisco Velazquez, MD
Claim this profilePioneer Research Solutions Inc
Studies Non-alcoholic Fatty Liver Disease
Studies Fatty Liver Disease
8 reported clinical trials
9 drugs studied
Area of expertise
1Non-alcoholic Fatty Liver Disease
Stage I
Stage II
2Fatty Liver Disease
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Francisco Velazquez, MD is currently running
HM15211
for Non-alcoholic Steatohepatitis (NASH)
This trial is testing a medication called HM15211 to see if it can help people with a liver disease called NASH. The study will check if the medication is safe and effective over a period of time.
Recruiting0 awards Phase 23 criteria
Pegloticase + Methotrexate
for Gout
The study consists of 24-week double-blind trial to evaluate the non-inferiority of the efficacy and safety of pegloticase Q4W with MTX versus pegloticase Q2W with MTX, followed by a 24-week open-label extension of pegloticase Q4W with MTX, in participants with uncontrolled refractory gout. The main objective of the study is to evaluate the effect of pegloticase 16 mg administered Q4W with MTX versus pegloticase 8 mg administered Q2W with MTX, on the response rate during Month 6, as measured by the sustained normalization of sUA to < 6 mg/dL for at least 80% of the time.
Recruiting3 awards Phase 4
More about Francisco Velazquez, MD
Clinical Trial Related4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Francisco Velazquez, MD has experience with
- Pegloticase
- Placebo
- ARO-APOC3
- HM15211
- Placebo Of HM15211
- CS0159 (Linafexor)
Breakdown of trials Francisco Velazquez, MD has run
Non-alcoholic Fatty Liver Disease
Fatty Liver Disease
Nonalcoholic Steatohepatitis
Type 2 Diabetes
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Francisco Velazquez, MD specialize in?
Francisco Velazquez, MD focuses on Non-alcoholic Fatty Liver Disease and Fatty Liver Disease. In particular, much of their work with Non-alcoholic Fatty Liver Disease has involved Stage I patients, or patients who are Stage II.
Is Francisco Velazquez, MD currently recruiting for clinical trials?
Yes, Francisco Velazquez, MD is currently recruiting for 3 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Francisco Velazquez, MD has studied deeply?
Yes, Francisco Velazquez, MD has studied treatments such as Pegloticase, Placebo, ARO-APOC3.
What is the best way to schedule an appointment with Francisco Velazquez, MD?
Apply for one of the trials that Francisco Velazquez, MD is conducting.
What is the office address of Francisco Velazquez, MD?
The office of Francisco Velazquez, MD is located at: Pioneer Research Solutions Inc, Houston, Texas 77099-4307 United States. This is the address for their practice at the Pioneer Research Solutions Inc.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.